Signet Ring Cell Adenocarcinoma
2 clinical trials · Condition
◉ Watch Signet Ring Cell Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin (NCT05504252) | University Hospital, Akershus | 2022-10-05 |
| Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers (NCT02978625) | National Cancer Institute (NCI) | 2017-09-27 |
Track Signet Ring Cell Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.